Management of spontaneous pneumomediastinum based on clinical experience of 25 cases  by Takada, Kazuto et al.
Respiratory Medicine (2008) 102, 1329e1334ava i lab le at www.sc ienced i rec t . com
journa l homepage : www.e lsev ier . com/ loca te / rmedManagement of spontaneous pneumomediastinum
based on clinical experience of 25 casesKazuto Takada*, Shuuichi Matsumoto, Tetsuo Hiramatsu, Eiji Kojima,
Hiroaki Watanabe, Masato Sizu, Shoutarou Okachi, Kiyoko NinomiyaDivision of Respiratory and Allergy Medicine, Komaki Municipal Hospital, 1-20 Johbuji, Komaki 485-8520, Japan
Received 3 January 2008; accepted 20 March 2008





pneumomediastinum* Corresponding author. Tel.: þ81 5
4516.
E-mail address: k-takada@komakih
0954-6111/$ - see front matter ª 200
doi:10.1016/j.rmed.2008.03.023Summary
Study objectives: Spontaneous pneumomediastinum (SPM) is a rare disorder that usually occurs in
young individuals and has a self-limiting course and no recurrence in most cases. But actually in
manycases,patients areundergo someexaminationsor some limitations. Thepurposeof this study
was to evaluate the clinical characteristics and recommend appropriate management of SPM.
Design: Retrospective research of clinical records of a single institution.
Results: Over 11 years, we diagnosed 25 patients (18 males) with SPM. Their average age was
20.1 years (range 13e28 years). Chest pain or neck symptoms were most frequent, and 17
patients (68%) had subcutaneous emphysema. In all cases, blood counts and C-reactive protein
(CRP) were measured, and their mean values were 10,100  4600/mm3 and 1.0  1.5 mg/dL, re-
spectively. In 20patients (80%), either leucocytosis or elevatedCRPwas observed. Twenty-four pa-
tients (96%) were admitted (average 7.8  4.1 days) and 20 of themwere prescribed antibiotics or
limited oral intake. The symptoms were self-limiting in all cases and disappeared on average
1.8  0.9 days after diagnosis. No recurrencewasnoted in the approximately 2 years follow-uppe-
riod.
Conclusion: SPM is a self-limiting disease with mild inflammatory signs. For patients suspicious of
SPM, shortened hospitalization for about 2 days with observation alone may be feasible, if their
symptoms improve gradually. Otherwise, less invasive procedures, such as esophagram, should
be performed immediately. Long-term follow-up is usually unnecessary. We propose a new algo-
rithm for management of SPM based on clinical experience.
ª 2008 Elsevier Ltd. All rights reserved.68 76 4131; fax: þ81 568 74
p.gr.jp (K. Takada).
8 Elsevier Ltd. All rights reservedIntroduction
Spontaneous pneumomediastinum (SPM) is a rare and self-
limiting disease that usually occurs in young adult males
without apparent concomitant factors or disease. It is
consistent in previous studies that SPM has a good clinical.
1330 K. Takada et al.course with very rare recurrence and complications. The
studies investigating the clinical course of SPM are reviewed
in Table 1. However, in many cases, patients undergo some
examinations, including invasive endoscopy, to rule out
esophageal rupture (Boerhaave syndrome) and are admit-
ted for observation for progression into tension pneumome-
diastinum, which may be fatal.1 In retrospective studies of
SPM, some authors have reported 5e8 days as the mean
length of hospital stay.2e4 This contradiction, that rela-
tively long hospitalization is required despite benign dis-
ease, results from a lack of clinical data, especially
regarding the course over time of SPM and the difficulty
of ruling out Boerhaave syndrome. If hospital stays can be
shortened, the physical and economic load burden on
patients will be reduced. The purpose of this study was to
investigate our clinical experiences from a single institution
and to propose better management of SPM.
Methods
All adult cases of SPM diagnosed and followed at Komaki
Municipal Hospital, a general hospital with a regional
emergency department, between April 1996 and October
2007 were investigated retrospectively. Pneumomediasti-
num was diagnosed by confirmation of free air in the
mediastinum on a chest X-ray or chest computerized
tomography (CT). ‘‘Spontaneous’’ pneumomediastinum
was pneumomediastinum that occurred without chest
trauma, mechanical ventilation, or surgical or medical
procedures.5 Pneumomediastinum that developed after in-
haling drugs, exercise, coughing and asthmatic attack was
included in SPM. Clinical data on patient history, physical
characteristics, symptoms, findings of examinations, length
of the hospital stay, treatments, clinical time course, re-
currence and complications were investigated carefully.
Leucocytosis and elevated C-reactive protein (CRP) were
defined as over 9000 mm3 and 0.5 mg/dL, respectively.
Fever was indicated with a body temperature higher than
37.2 C.
The follow-up period was defined as the time from
discharge to the last visit to our hospital. The number of
days from the appearance of symptoms to the first visit and
to disappearance of symptoms was also reviewed.Table 1 Summary of clinical literature on spontaneous pneumo
Author Number Mean age
Jougon [1] 12 25
Miura [2] 8 17.5
Abolnik [3] 25 18
Macia [4] 41 21.3
Newcomb [6] 18 20
Mondello [7] 18 25
Freixinet [17] 32 21
Gerazouris [18] 22 12e32
Koullias [19] 24 17.5
Weissberg [26] 22 15e37
LOS, length of the hospital stay; NR, not reported.Results
During the 11-year study period, 25 patients were di-
agnosed with SPM (Table 2).
The average age of the patients at diagnosis was
20.1 years (range 13e28 years), and most (72%) were
male. The mean body mass index (BMI) was 20.2  4.0 kg/
m2. All patients had one or more symptoms at the first visit
(Table 3).
Acute onset retrosternal chest pain (68%), dyspnea (44%)
and throat symptoms (discomfort or pain) (52%) were seen
frequently, but no severe cases that exhibited symptoms
such as aglutition or inability to rest were included. After
careful review, trigger events were determined in 14 cases
(56%), mainly mild asthma attacks and exercise such as
soccer, but no trigger events were detected for 11 patients
(44%). The average time from presentation of symptoms to
the first visit was 1.0  1.5 days (Table 4).
Physical findings and blood examinations at the first visit
are shown in Table 5. Despite the retrospective study, blood
counts and biochemistry examinations were available in all
cases.
Among the physical findings, subcutaneous emphysema
was detected in 17 patients (68%), mainly distributed in the
shoulder and neck. No auscultatory abnormalities were
detected, including Hamman’s sign. Even in the cases with
dyspnea, no desaturation was recorded in room air.
Although fever was recorded in 7 patients (28%), only 1
patient had a high fever, above 38.5 C. The average time to
reduce fever was 1.5  0.2 days. Elevated CRP was seen in
10 patients (40%), but no case was over 5.0 mg/dL. Interest-
ingly, the patients with CRP over 2.0 mg/dL were all asth-
matic. Leucocytosis was detected in 14 patients (56%), and
2 of 3 patients with moderate leucocytosis (more than
15,000/mm3) were also asthmatic. As a result, 20 cases
(80%) had either leucocytosis or elevated CRP.
All patients SPM was suspected based on symptomatic
chest X-ray examination, except in one patient who had
remarkable subcutaneous emphysema. In most cases, chest
CT was performed to confirm the diagnosis, and no
additional information, such as concomitant pneumotho-
rax, was found. A typical chest CT of SPM is shown in Fig. 1.
After diagnosis, some examinations were added formediastinum














Table 4 Clinical course
Average time Days (average 
standard deviation)
From presentation to the first visit 1.0  1.5
From diagnosis to disappearance
of symptoms
1.8  0.9
Length of hospital stay 7.8  4.1
Follow-up time 673.9  880.2
Table 2 Characteristics of patientsa





Age (years)a 20.1  4.8
Height (cm)a 166.0  7.0
Weight (kg)a 56.1  13.8
Body mass index (kg/m2)a 20.2  4.0




a Data are shown as mean  standard deviation.
Table 5 Examinations and findings
Physical examinations Number of patients
(percentage)
Subcutaneous emphysema 17 (68)
Hamman’s sign 0 (0)
Body temperature (BT) (C)
36.9  0.7a
25 (100)
BT < 37.2 18 (72)
37.2 BT < 38.5 6 (24)
BT  38.5 1 (4)
SpO2 96.6  2.2 (%, room air)a 25 (100)
Management of spontaneous pneumomediastinum 1331a differential diagnosis, such as bronchoscopy, esophagram
and esophagoscope (Table 5), but no additional findings,
including esophageal and tracheobronchial rupture, were
detected.
Treatments are summarized in Table 6. All but one, who
received emergency examination, were admitted urgently,
managedwith bed-rest and prescribed analgesics as needed.
Manywere prescribed prophylactic antibiotics (76%) and lim-
ited oral intake (48%) to prevent mediastinitis (Table 6).
No patients were treated with subcutaneous drainage or
oxygen during their hospital stay. All patients had a good
clinical course with no deterioration or complications such
as subcutaneous or mediastinal emphysema. The symptoms
were self-limiting and disappeared about 2 days after diag-
nosis. However, the average hospital stay was 8 days (rang-
ing from 3 to 21 days, Table 4), mainly for observation. In
our study cases, no recurrence was found during the fol-
low-up period (average 673  880 days, Table 6).
Discussion
In this retrospective study, SPM was confirmed as a self-
limiting disease with little complications and recurrence.Table 3 Symptoms and trigger events
Number of patients (%)
Symptoms
Chest pain 17 (68)
Dyspnea 11 (44)
Throat pain 7 (28)
Throat discomfort 6 (24)
Neck pain 5 (20)
Dysphagia 2 (8)
Trigger events
Asthma attack 6 (24)
Exercise 4 (16)
Cough 2 (8)
Drug inhalation 1 (4)
Vomiting 1 (4)
Nothing 11 (44)Patients with clinical suspicion of SPM may be managed
with observation alone without prophylactic antibiotics,
limits on oral intake or additional examinations. Further-
more, about 2 days, the average time to ameliorate
symptoms, appears a reasonable duration for observation
in hospital if their symptoms improve gradually. Inversely
if the clinical course is suboptimal, then less invasive proce-
dures such as chest CT or esophagram should be added im-
mediately. Based on these findings, we propose an
algorithm for management of SPM (Fig. 2). Although a simi-
lar algorithm to diagnose SPM has already been pro-
posed,13,15 this algorithm can aid management of SPM
after diagnosis.
First pneumomediastinum was described in chest trauma
cases6 and the first description of SPM was provided






WBC < 9000 11 (44)
9000 WBC < 15,000 11 (44)
WBC  15,000 3 (12)
CRP (mg/dL) 1.0  1.5a
CRP < 0.5 15 (60)
0.5  CRP < 2.0 6 (24)
2.0  CRP < 5.0 4 (16)





SpO2, percutaneous oxygen saturation; WBC, white blood cells;
CRP, C-reactive protein.
a Data are shown as mean  standard deviation.
Figure 1 Chest CT illustrating pneumomediastinum (arrows).
Figure 2 Management algorism of spontaneous
pneumomediastinum.
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more recently it is has been defined as pneumomediastinum
that occurs suddenly without surgery, trauma, other organ
rupture and mechanical ventilation. Some authors exclude
pneumomediastinum resulting from physical activity2 and
associated with pulmonary disease8 from spontaneous
cases. On the other hand, pediatric review notes that
exclude pneumomediastinum associated with pulmonary
disease from SPM have no clinical value.5
A mechanism for SPM was proposed using an animal
model9 and it was confirmed by pathological10 and radiolog-
ical investigations.11
The incidence of SPM in the present study was 1/10,470
inpatients of our hospital (0.0095%), similar to that found
by other authors: 0.002%12 and 0.003%13 in general hospi-
tals, 0.003%3 in a university hospital and 0.014% in a military
hospital.14 Despite the differences in the criteria for SPM,
the difficulty of diagnosis and differences in hospitals, it
is clear that the SPM is very rare.
Most of our study group were young males
(20.1  4.8 years, male 72%) with retrosternal chest pain,
dyspnea and throat symptoms, such as pain or discomfort,
consistent with other authors (Table 1).4,13e17 Although no
severe symptoms were noted, the average time from
onset to the first visit was 1.0 day, so the symptoms may





Prophylactic antibiotics 19 (76)
Limitation of oral intake 12 (48)
Observation alone 5 (20)
Complications 0 (0)
Recurrence 0 (0)Previously SPM has been reported to be predominant in
thin patients, as well as spontaneous pneumothorax, but the
patient’s BMI is not always low; averaged 20.2  4.0 kg/m2 in
the present study, 19.9  1.4 kg/m2 and 21.1  2.0 kg/m2 in
other studies.1,2
Subcutaneous emphysema was seen in 68% of patients.
The reported frequency varies in studies, ranging from 40%
to 100%2,4,13,17e20 but is roughly 50% in most studies. Some
authors described subcutaneous emphysema as a good
clinical sign because the air leaking into the subcutaneous
tissue prevents an increase in intra-mediastinum pressure,
which compresses the major vessels.21
Hamman’s sign is crackles or bubble sounds heard with
each beat of the heart and is well known as an auscultative
sign of SPM. No auscultative abnormalities were detected in
this study, and other authors also describe such findings as
rare.13,14,17 One reason may be the inaccuracy of ausculta-
tion: it is important to auscultate in the left lateral position
to amplify the sound.2 Regardless, it is difficult to diagnose
based on physiologic examinations alone.
Some reported that one-third of patients are not
detected by posterioreanterior chest X-ray alone,22 so
careful examination or additional lateral chest X-rays are
needed. Furthermore, a chest CT is recommended in cases
where SPM is strongly suspected. Zylak et al. reviewed
radiological signs of SPM in detail.23
At the first visit, mild elevation of CRP or leucocytosis
was seen in 20 cases (80%). Although these inflammatory
signs have been reported previously in studies with small
patient groups, this is the first study to provide verification
in the whole group with more than 20 patients. Some also
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elevated CRP in a group of 8 patients.2 In other studies, fe-
ver below 38.5 C was recorded in 22%,15 and 41% of pa-
tients were found to have leucocytosis and/or
neutrophilia.4 Mild asthmatic attacks occurred in most
cases in this study with CRP over 2.0 mg/dL or leucocytosis
above 15,000/mm3. The reasons may be an infection that
caused the asthma attack or as a direct result of the asthma
attack. Mild inflammatory signs may provide clinicians with
additional information at initial assessment in a primary
setting to decide whether emergency examinations to
rule out Boerhaave syndrome should be performed or not.
If severe inflammation or symptoms are detected in
suspected cases of SPM, Boerhaave syndrome should be
ruled out first because it may lead to mediastinitis and may
occasionally be fatal; the reported mortality rate ranges
from 30% to 50%.24
A chest CT should be performed first; the typical findings
of chest CT of Boerhaave syndrome are described else-
where.24 Some authors have described endoscopic exami-
nations as risky,1 so an esophagram may be the better
choice as a minimally invasive and safe procedure. One
option in the choice of contrast medium is to use water-
soluble material first and, if there are no findings, then
follow with barium to improve sensitivity.5 Esophagram
using water-soluble material may fail to detect esophageal
rupture in one-quarter of cases.24 Barium is more radi-
opaque but can cause an inflammatory change and subse-
quent fibrosis in the mediastinum.
Unless severe symptoms or inflammatory signs are
detected, it may be enough to observe the patient without
invasive examinations.1,2,16,19,25 Many cases in this study
were given prophylactic antibiotics or limited oral intake
to prevent mediastinitis, but these are consequently unnec-
essary. Despite the reports that 100% oxygen supply encour-
ages rapid absorption of emphysema, this is not supported
by evidence and is not recommended routinely.5 Removal
of subcutaneous air may be indicated for patients with
progressive subcutaneous emphysema; in such cases, pro-
phylactic antibiotics are recommended.15
All symptoms were self-limiting and the average time to
disappearance was 1.8 days after diagnosis in this study
(Table 4) and within 7 days,3 3e15 days,5 and 4e5 days17
in other studies. No complications, such as pneumothorax
or tension pneumomediastinum that were reported in
animal models,9 were observed in the present study, which
was similar to other recent studies (Table 1).1e4,17e19,22,26
All patients had a good clinical course with no deterioration
of emphysema and an average of 7.8 days hospitalization.
Thus, most patients had an excessive observational period
and underwent examinations, including endoscopies, that
detected no additional findings. Early discharge can be
recommended for patients without progressive emphysema
needing subcutaneous drainage or without suspicion of
severe organ rupture such as Boerhaave syndrome. Previous
authors have noted occasional early discharge,
24e48 h,17,18 and their empirical experiences are similar
to the time we found for symptoms to disappear, so approx-
imately 2 days may be a feasible duration for observational
hospitalization.
During the 2 years follow-up period after discharge,
there were no recurrences. Recurrence is thoughtextremely rare (Table 1), however some authors have
reported recurrent cases.3,4,27 Although long-term follow-
up may not be needed, the possibility of recurrence must
be recognized, and at any point it should be emphasized
that examinations to differentiate from other organ rup-
tures must be added immediately in all cases without
good clinical course.
A greater accumulation of patients or a prospective
study with a standardized diagnostic protocol is needed to
validate the feasibility of shortened hospitalization without
additional examinations and limitations.
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